Calcific embolization with infective endocarditis involving the posterior mitral leaflet in a patient with underlying

Navneet Lather1, Kyle Niziolek, Peter Toth

  • 1Division of Cardiovascular Diseases, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH, 45267, USA, lathernt@ucmail.uc.edu.

Insights

This case study details infective endocarditis (IE) affecting the posterior mitral leaflet in hypertrophic obstructive cardiomyopathy (HOCM). It highlights rare PML involvement and associated complications, offering new insights into HOCM-IE presentations.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Cardiovascular Surgery

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) typically involves anterior mitral leaflet endocarditis in cases of infective endocarditis (IE).
  • Recurrent outflow obstruction and valvular regurgitation in HOCM patients predispose to endocardial damage, primarily on the anterior mitral leaflet and basal septal myocardium.
  • Infective endocarditis presents unique challenges in patients with complex cardiac conditions like HOCM.

Observation:

  • A rare case of infective endocarditis involving the posterior mitral leaflet (PML) was observed in a patient with HOCM.
  • The patient experienced calcific embolization, leading to repeated embolic strokes.
  • Management was complicated by moderate mitral stenosis, dynamic left ventricular outflow tract obstruction, and flash pulmonary edema.

Findings:

  • This is the first reported instance of posterior mitral leaflet (PML) involvement in infective endocarditis (IE) within the context of hypertrophic obstructive cardiomyopathy (HOCM).
  • Calcific embolization from the infected PML resulted in significant neurological complications.
  • The co-occurrence of mitral stenosis, dynamic left ventricular outflow tract obstruction, and pulmonary edema complicated the clinical course.

Implications:

  • This case expands the understanding of potential IE manifestations in HOCM, particularly concerning posterior mitral leaflet involvement.
  • Recognizing this rare presentation is crucial for timely diagnosis and appropriate management strategies in HOCM patients with IE.
  • Further research may elucidate the specific mechanisms leading to PML endocarditis in HOCM and inform treatment protocols.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
511
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
359
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
746
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
1.1K